Doc Akers-White Faces Secret Federal Ruling: What Happened?
Published Date: 12/4/2025
Notice
Summary
Dr. Latania Akers-White from Virginia lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing to challenge this, so the DEA officially revoked her registration as of June 30, 2025. This means she can’t prescribe or manage controlled drugs anymore, affecting her medical practice and patients.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Dr. Akers-White
The DEA revoked Latania Akers-White, M.D.'s Certificate of Registration No. FA2343630 and denied any pending applications to renew, modify, or add registrations in Virginia. The registration revocation order is effective January 5, 2026; her DEA registration had expired on June 30, 2025 and her Virginia medical license was suspended on or about July 11, 2024.
DEA Authority When State License Suspended
Under 21 U.S.C. 824(a)(3) and related provisions, the DEA may suspend or revoke a practitioner's registration when the practitioner's State license or registration has been suspended or revoked so that the practitioner is no longer authorized to handle controlled substances in that State. The agency states that a practitioner must have state authority to dispense controlled substances in the State where they practice to be eligible to maintain a DEA registration.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20750, L Krenk DBA Maui Clinic Pharmacy; Decision and Order
The DEA has officially revoked L Krenk DBA Maui Clinic Pharmacy’s registration because they broke important rules about where and how they handled controlled substances. This affects the pharmacy in Kahului, Hawaii, which can no longer legally dispense these drugs. The decision is final, and the pharmacy missed its chance to defend itself, so the revocation takes effect immediately, impacting their business and customers.
2026-20757, Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
The DEA is removing the special exemption for certain inactive butalbital prescription products that are no longer made or sold. Starting November 9, 2026, these products won’t be treated as exempt under drug laws anymore, but active products stay the same. This change mainly affects drug companies and pharmacies handling these old products, with no new costs for active medicines.
Previous / Next Documents
Previous: 2025-21884, Agency Information Collection Activities; Submission of Proposed Information Collection; Online Training Request Form for OMB Review
The Access Board is asking for approval to start a new online form that lets people and local governments easily request training. This change makes it simpler to get help and doesn’t cost anyone extra. You can share your thoughts on this plan until January 5, 2026.
Next: 2025-21886, Endangered and Threatened Species; Issuance of Enhancement of Survival and Incidental Take Permits for Safe Harbor Agreements, Candidate Conservation Agreements, Conservation Plans, and Recovery Activities; January 1, 2024, Through December 31, 2024
The U.S. Fish and Wildlife Service is sharing a list of permits issued in 2024 that allow certain activities affecting endangered and threatened species. These permits help people and groups safely work on conservation projects, recovery efforts, and habitat plans without breaking the law. This update keeps everyone informed about who’s involved, what’s allowed, and when these permits apply throughout the year.